Dr. Chander is a physician, neuroscientist, and futurist who trained at Harvard, UCSF, UCSD, and the Salk Institute. She is Chair of Neuroscience and Faculty of Medicine at Singularity University, Visiting Scholar in Medicine (Bioinformatics) at Stanford (where she was on the Anesthesiology faculty for 8 years), and Senior Fellow at the Atlantic Council GeoTech Center. Her postdoctoral research allowed her to use light-activated ion channels inserted in DNA (optogenetics) to study sleep and consciousness switches in brains. Her goal is to understand neural mechanisms of consciousness, the evolution of human consciousness secondary to human augmentation, and how mapping consciousness in humans may help us to understand consciousness and intelligence in other life forms (e.g. animals, non-terrestrials).
During the Covid19 crisis, she now leads or advises 3 pandemic task forces, including One Shared World’s Global Pandemic Resilience Task Force, a NASA-White House Telehealth task force, and a re-open strategy for the state of California. In response to the need for global resilience, she cofounded Plexxus, a company building the world’s connected global immune system. She is also founder and CEO of lucidify, a tele-neuroICU platform, backed by AI, to map and diagnose brain dysfunction in patients.
Dr. Chander also contributes to space life sciences and medicine. A finalist for astronaut selection and an alumnus of the International Space University, Dr. Chander has performed remote simulations of trauma rescues, anesthesia and surgery in Mars analogue settings with physicians in the US, France, and the Concordia base in Antarctica. She has also been involved with a consortium that elaborated a road-map for studying the effect of microgravity and radiation on the nervous system, cardiovascular system, cognition and sleep. She wishes someday to see the Earth rise from the surface of the moon.
The technological Singularity is a hypothetical future point in time at which exponential technological growth results in unforeseeable changes to human civilization. In the most extreme vision of the Singularity, machine intelligence explodes, first surpassing human intelligence and then reaching artificial superintelligence. Futurists and thinkers such as John von Neumann, Verner Vinge, and Ray Kurzweill have posited that the Singularity may come about within the next several decades, with Kurzweill announcing "I have set the date 2045 for the "Singularity"; which is when we will multiply our effective intelligence a billion-fold by merging with the intelligence we have created.";
In this talk we ask, are we even close to the mark of artificial general intelligence (when machines can perform and solve complex tasks, much like humans), much less artificial superintelligence, which some scientists and technologists have feared could lead to a human extinction level event? What is required for machines to reach this level of intelligence, and are the technologies we have currently building enabling us to proceed along that arc? Are there other enabling technologies on similar exponential trajectories like synthetic biology, robotics, and nanotechnology?
This talk will explore relevant exponential technology curves in multiple verticals, and whether this trend has the potential to bring us close to a Singularity level event. Participants will gain an understanding of the vision that Singularity University was founded on, and how their business, leadership, or investment strategies might help us forge the future that is best for humanity.
Recent advances in large language models, or generative AI, have begun to make people question whether Kurzweil's prediction of the Singularity may be coming to pass in the near future. To make sense of this, we need to first understand the difference between artificial intelligence and artificial generative intelligence and how these might be different or similar to neural intelligence expressed by organic brains.
The journey will require that we think about fundamental universal concepts such as the definition of life, consciousness, embodiment, and complexity. And it will bring up significant ethical considerations. Can generative AI be used to read and write to the human brain, body and genome without informed consent? Can such intelligences be used to understand other intelligences on Earth, such as animal intelligence? Do machines or algorithms that express anything along the axis of intelligence to sentience deserve basic fundamental rights? Will generative AI be used to create new life forms? Will humans use AI to exploit other humans, or will an artificial general intelligence directly exploit humans without further human direction? And if the Singularity is achieved, what does this bode for our expansion into the universe?
This is a visionary Singularity style talk, great for an opening keynote, that sets the tone for any type of SU event. It is relevant to all business leaders, investors, entrepreneurs, scientists, technologists, robotics/AI/neurotech professionals, government, and students; related to the mission of Singularity, using exponential tech to solve for GGCs.
There has been a lot of recent hype around generative AI and the network models they are based on. Importantly, they are being seen and touted, whether correctly or not, as the point of inflection for the Singularity - where machine intelligence crosses the curve for organic intelligence, and artificial general intelligence becomes possible. But these models are actually just advances in the algorithms that have formed the foundation of brain reading technology and brain computer interfaces. In this talk, we explore this foundational neurotechnology, talk about the ways in which new AI models support unlocking more meaning from BCI mind reading, enable more sophisticated mechanisms for writing to the brain, connecting the brain to the machines and the web, and open up the door for human personhood to be hacked.
This talk was very relevant to the types of crowds drawn to Exponential Medicine – healthcare executives, physicians, scientists, technologists, and investors. It is also particularly relevant to those interested in AI and robotics, and their impact. When presented at SciFoo, many of the AI, computing, quantum developers and investors were interested. It touches on the power of exponential technology to change and amplify human potential. Related to the mission of Singularity, using exponential tech to solve for GGCs.
In an age in which both the neural and genetic code are being digitized, there are new opportunities for precision medicine, drug discovery, and healing. This kind of mapping offers the promise for correcting genedefects, replacing body parts that have failed, and connecting the human brain to machines. These kinds of interventions also open humans to the possibility of enhancement and augmentation – building “superhumans” – that can potentially evolve beyond the boundaries of Homo sapiens. They also open the door for human manipulation and hacking. Explore the boundaries of this new interface of brain, genome, robotics, AI and human-directed evolution, while understanding the new cybersecurity implications of this new technology.
This talk weaves genetics/genomic editing, syn-bio, neurotechnology, AI, bionics and XR to demonstrate the power of exponential technology in changing human potential. It is relevant to all business leaders, investors, entrepreneurs, scientists, technologists, robotics/AI/neurotech professionals, government, and students; related to the mission of Singularity, using exponential tech to solve for GGCs.
The science to delay, arrest or reverse human aging is making exponential strides. How will we get there? What does that future look like? Will it be democratized? Will it be accepted?
In this talk, which verges on science-fiction-made-reality, we’ll explore what science tells us about living longer, what we are doing to realize this goal (e.g., technologies like CRISPR, brain machine interfaces, human augmentation), and how this may affect the psychology and future of the human species. But longevity is not just a healthcare issue—extending human lifespans to even 120 or 130 years will affect every industry, every vertical, and have a massive impact on adjacent technologies and global markets. Longevity affects all stakeholders. It also comes with risk and responsibility. Ultimately, understanding human longevity becomes a journey to understanding where our species’ destiny lies.
Upon completion, attendees should be able to:
1. Understand longevity technology as having dual use, and the ethical issues that arise from its development.
2. Recognize the impact of longevity on different verticals—health, business, infrastructure, finance, energy and biosphere.
This talk weaves neurotechnology, AI, bionics and XR to demonstrate the power of exponential technology in changing human potential. It is relevant to all business leaders, investors, entrepreneurs, scientists, technologists, robotics/AI/neurotech professionals, government, and students; related to the mission of Singularity, using exponential tech to solve for GGCs.
Extended Reality (XR) encompasses various immersive technologies that extend or enhance our perception of reality. The intersection of AR and VR and the intersection with the metaverse, spatial computing, Web 3.0 and digital twins holds huge promise for healthcare. There are opportunities to train the next generation of medical professionals, empower patients, and enhance human-machine interactions for diagnosis and therapeutics. However, the imperative to safeguard biometric data and ensure informed consent remains paramount. As we continue to navigate this evolving landscape, striking the right balance between innovation and ethics will be the key to realizing the full potential of XR in healthcare while safeguarding individual privacy and data rights.
Relevant to Investors, regulators, companies, technologists, healthcare execs (c-suite), and educators interested in health, web 3.0, spatial computing, digital twinning, and simulation.
Digital health and associated spheres like medical extended reality, wearables, sensors and implantables, provide new opportunities for extended healthcare access and medical training to a wide swath of the population. Further, (next) pandemic resilience requires the creation of integrated warning systems that can collect and integrate sensitive data at the edge. In many cases, the data collected passively and actively by devices at the edge include biometrics and biometrically-inferred data – the most sensitive data we own. User identification, authentication, data collection, storage, and connectivity on both decentralized and aggregated networks create new threat landscapes that are exacerbated by key edge vulnerabilities. In this talk, we explore some of this new risk landscape, as well as new network solutions and frameworks that provide means for user-centric control, security, and privacy, which will revolutionize both cyberhealth networks as well as edge-based user interactions with Web 3.0 and the metaverse.
In this talk, you will learn:
1. How to think about the dizzying new array of data collection types and data producers that can be used for intelligent healthcare;
2. How health and wellness shifted into the commercial market create new opportunities for monitoring, wellness, and risk;
3. How interactions between biometrics and commercial endeavors, including Web 3.0 and the burgeoning metaverse, create new opportunities and biometric risk;
4. How humans can be literally hacked and subject to ransomware, much as machines and software;
5. How future internet architectures and exponential thinking might enhance cybersecurity and user-centric control at the network's edge.
6. How businesses and governments can protect against these threats.
Understanding consciousness has been one of the grandest endeavors for humankind, but despite all we have learned about the brain through mapping, we have not truly been able to define what consciousness is.
In this talk, we explore how to measure consciousness, new ways to define it, and even new theories for understanding its origins. How can we use anesthetic and psychedelic drugs as perturbing functions in these complex, non-linear dynamical systems to understand more about the system, Is consciousness uniquely human, Is it spatially or temporally constrained. In addition, the connection to animal consciousness and potentially exploring the universe for extra-terrestrial intelligence (SETI) is explored. Fundamentally, understanding this question is about defining who we are.
This is a visionary Singularity style talk, great for an opening or closing keynote or to set the tone for any type of SU event that spurs new discussion and innovation. It is relevant to all business leaders, investors, entrepreneurs, scientists, technologists, robotics/AI/neurotech professionals, the government, and students.
The harsh realities of space - cosmic radiation, microgravity, and the isolation of deep space - pose profound challenges to human survival. However, leveraging synthetic biology might help humans to explore space and thrive. This talk will take the audience on a tour of the many aspects of syn-bio, including molecular manufacturing, gene editing, food and habitat printing, data storage, to demonstrate how it might be used to enable human survival in space, on long-duration deep space missions, and on other solar system bodies. But this biotechnology has full reverse spin-off to Earth-based medicine, human resilience, and protection of the biosphere. Lessons learned by exploring syn-bio in space will enable us to use this exponential technology to address the global grand challenges on Earth, helping humans and other species to adapt and thrive and cultivate more sustainable practices here on Earth, contributing to a greener and more resilient planet.
This talk has a Singularity-style visionary aspect to it. It is relevant to all business leaders, investors, entrepreneurs, government, students; related to SDGs (health, wellness, food, space) and using exponential tech to solve for global grand challenges; especially good for investors and executives in pharma, health, agriculture, environment/geoengineering, biotech, and longevity; useful for regulators, governments.
Synthetic biology combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems, or to redesign existing biological systems for useful purposes. It offers potent uses cases across various industries, including biology and medicine. In this talk we will cover the ways in which synthetic biology enables us to engineer cells, DNA, target drug delivery, or design new therapeutics. It can also be used for drug discovery, novel environmental sensors, or even biomonitoring and clean-up. Bio-manufacturing capabilities will contribute to securing food systems, developing planetary resilience, and even enabling the human exploration of space. But there are definite dual use cases, some of which involve engineering organisms for more destructive capabilities or bioterrorism. We will close by considering the ethical, social, and regulatory aspects to ensure responsible and safe deployment of synthetic biology technologies to support humanity and the biosphere.
Relavent to SU visionary style. Relevant to all business leaders, investors, entrepreneurs, government, students; related to SDGs and using exponential tech to solve for global grand challenges; especially good for investors and executives in pharma, health, agriculture, environment/geoengineering, biotech, and longevity; useful for regulators, governments.
Synthetic biology empowers us to reprogram and engineer living organisms, creating new modes of on and off-planet manufacturing, and novel solutions to some of the most pressing challenges facing humanity today. It touches on almost every global grand challenge we face, including food security, sustainable habitats, personalized medicine, CRISPR-based therapeutics, novel materials, computing and data storage, and cleaner energy production. During this talk, we will explore fundamental concepts of synthetic biology, examining how scientists manipulate DNA, genes, and cells to design and construct new biological editing and manufacturing systems. The exponential increases in artificial intelligence and computing power coupled with decreases in cost have enabled this to move out of the lab and into practice, spurring new commercial innovation. We will also look at the ethical implications, responsible innovation, and how we might approach using these technologies for cyber and bio-defense threats. Startups and corporations alike are deploying biotechnology to innovate in allowing humans to flourish, protect our biosphere, and disrupt markets and industries and addressing the grand challenges of our time, from climate change to global health to energy production. Government and industry need a syn-bio strategy. By exploring the world of engineered life, we can discover how it will shape the future.
Relevant to all business leaders, investors, entrepreneurs, scientists, technologists, cyber and bioterrorism professionals, government, students; related to SDGs and using exponential tech to solve for global grand challenges.
The brain’s natural state is to be plastic, or changeable, and in very profound ways. But brains are also hardwired in evolution to follow and take the path of least resistance. Tools of neuroscience, like brain imaging, can be used to both understand the circuits and the behaviors underpinning the activity of excellent leaders. Neurofeedback and specific behaviors can be used to enhance these qualities. In this talk, we will look at the science behind our established behavioral patterns and how they affect creativity, innovation, and trust. We can then apply this science to improve an individual's leadership style, and to create dynamic, exponential organizations, in which the humans under a leader's direction can thrive and innovate.
Relevant to Business execs, leadership/c-suite, companies trying to build and foster environments of trust, creativity, and innovation. Methods have grounding in science.
In a rapidly evolving technological landscape, where our biology is becoming digital, the convergence of biometrics, global business, and ethics has created an interesting frontier. In this talk, you will see how biometric data advances are reshaping business, from healthcare to finance to Web 3.0 and spatial computing, moving a borderless economy forward. This technology also highlights emerging cybersecurity threat landscapes as human biology and enhancements become hackable targets, threatening personal privacy and safety. Learn what governments and business can do to proactively safeguard biometric innovation, protect individuals from the vulnerabilities of the connected human-cyber world, and embrace the role of responsible innovation in this new economy.
Relevant to business execs, leadership/c-suite, IT, cybersec, Web 3.0, metaverse/XR (VR/AR) industry, government, regulators, companies trying to build cybersecurity and privacy into their products from the ground up.